Obesity and brain addiction circuitry: Implications for deep brain stimulation

Neurosurgery

Volumn 71, Issue 2, 2012, Pages 224-238

  Taghva, Alexander ^a,c   Corrigan, John D ^b   Rezai, Ali R ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Deep brain stimulation; Food addiction; Neuromodulation; Obesity

Indexed keywords

LEPTIN; MESSENGER RNA; NEUROTRANSMITTER UPTAKE INHIBITOR; RIMONABANT; SILBUTRAMINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ABNORMAL FECES; ANASTOMOSIS LEAKAGE; ANTERIOR CINGULATE; ANTERIOR INSULA; ANXIETY; BARIATRIC SURGERY; BODY MASS; BRAIN DEPTH STIMULATION; CENTRAL NUCLEUS (AMYGDALA); CINGULATE GYRUS; COGNITION; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; CORPUS STRIATUM; DEPRESSION; DRUG SAFETY; FECES INCONTINENCE; FEEDING; FOOD ADDICTION; FUNCTIONAL NEUROIMAGING; GASTRIC BANDING; GASTROINTESTINAL DISEASE; GASTROJEJUNOSTOMY; HEART DISEASE; HUMAN; HYPERTENSION; HYPOTHALAMUS; LIMBIC SYSTEM; META ANALYSIS; MORBID OBESITY; NAUSEA; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SLEEVE GASTRECTOMY; STOMACH BYPASS; STRIA TERMINALIS; THIAMINE DEFICIENCY; WEIGHT REDUCTION; WOUND INFECTION;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; DEEP BRAIN STIMULATION; HUMANS; MODELS, NEUROLOGICAL; NERVE NET; OBESITY;

EID: 84864277797     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31825972ab     Document Type: Review

References (166)

1. NHLBI obesity Education Initiative Expert Panel. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: NHLB; 1998.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307(5):491-497.
4. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288(14):1723-1727.
5. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291(23):2847-2850.
6. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288 (14):1728-1732.
7. Ogden CL, Carroll MD. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1976-1980 Through 2007-2008. Atlanta, GA: NCHS, CDC; 2010.
8. US Department of Health and Human Services. Overweight and obesity: a major public health issue. Prev Rep 2001;16(1).
9. World Health Organization. Obesity and overweight, fact sheet No.311 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed February 19, 2012.
10. World Health Organization. Obesity and overweight. In: Global Strategy on Diet, Physical Activity, and Health. Geneva, Switzerland: WHO; 2003.
11. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861-1867.
12. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822-w831.
13. Könner AC, Klöckener T, Brüning JC. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav. 2009;97(5): 632-638.
14. Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 1999;848(1-2):114-123.
15. Hommel JD, Trinko R, Sears RM, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51(6):801-810.
16. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357(9253):354-357.
17. Shaw K, Gennat H, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006;(4):CD003817.
18. Shaw K, O'Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005;(2):CD003818.
19. Kleinridders A, Könner AC, Brüning JC. CNS-targets in control of energy and glucose homeostasis. Curr Opin Pharmacol. 2009;9(6):794-804.
20. Hukshorn CJ, van Dielen FM, Buurman WA, Westerterp-Plantenga MS, Campfield LA, Saris WH. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int J Obes Relat Metab Disord. 2002;26(4):504-509.
21. Neary NM, McGowan BM, Monteiro MP, Jesudason DR, Ghatei MA, Bloom SR. No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration. Int J Obes (Lond). 2008;32(9):1438-1440.
22. Kreier F. To be, or not to be obese-that's the challenge: a hypothesis on the cortical inhibition of the hypothalamus and its therapeutical consequences. Med Hypotheses. 2010;75(2):214-217.
23. Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring). 2010;18(2):221-229.
24. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194- 1199.
25. Pollack A. Abbott Labs withdraws Meridia from the market. New York Times. October 9, 2010.
26. Curioni C, André C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev. 2006(4):CD006162.
27. Suicide risk fears over diet pill. BBC News. June 15, 2007.
28. NIH Conference: gastrointestinal surgery for severe obesity: Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956-961.
29. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737.
30. Pisapia JM, Halpern CH, Williams NN, Wadden TA, Baltuch GH, Stein SC. Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study. Neurosurg Focus. 2010;29(2):E15.
31. Bal B, Koch TR, Finelli FC, Sarr MG. Managing medical and surgical disorders after divided Roux-en-Y gastric bypass surgery. Nat Rev Gastroenterol Hepatol. 2010;7(6):320-334.
32. Christou NV, Look D, Maclean LD. Weight gain after short-and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244 (5):734-740.
33. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 1999;22(2):221-232.
34. King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav. 2006;87(2): 221-244.
35. Hetherington AW, Ranson SW. Hypothalamic lesions and adiposity in the rat. Anat Rec. 1940;78(2):149-172.
36. Anand BK, Brobeck JR. Localization of a "feeding center" in the hypothalamus of the rat. Proc Soc Exp Biol Med. 1951;77(2):323-324.
37. Gold RM. Hypothalamic obesity: the myth of the ventromedial nucleus. Science. 1973;182(4111):488-490.
38. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372 (6505):425-432.
39. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411 (6836):480-484.
40. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377(6549): 530-532.
41. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 1996;45(4):531-535.
42. Presse F, Sorokovsky I, Max JP, Nicolaidis S, Nahon JL. Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience. 1996;71(3):735-745.
43. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR. Melaninconcentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology. 1997;138(1):351-355.
44. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 1998;396 (6712):670-674.
45. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573-585.
46. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95(1): 322-327.
47. Qu D, Ludwig DS, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature. 1996;380(6571): 243-247.
48. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250-252.
49. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med. 1995;1(12):1311-1314.
50. Bouret SG, Draper SJ, Simerly RB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci. 2004;24(11):2797- 2805.
51. Ahima RS, Antwi DA. Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am. 2008;37(4):811-823.
52. Herberg LJ, Blundell JE. Lateral hypothalamus: hoarding behavior elicited by electrical stimulation. Science. 1967;155(3760):349-350.
53. Stenger J, Fournier T, Bielajew C. The effects of chronic ventromedial hypothalamic stimulation on weight gain in rats. Physiol Behav. 1991;50(6): 1209-1213.
54. Brown FD, Fessler RG, Rachlin JR, Mullan S. Changes in food intake with electrical stimulation of the ventromedial hypothalamus in dogs. J Neurosurg. 1984;60(6):1253-1257.
55. Takaki A, Aou S, Oomura Y, Okada E, Hori T. Feeding suppression elicited by electrical and chemical stimulations of monkey hypothalamus. Am J Physiol. 1992;262(4 pt 2):R586-R594.
56. Sani S, Jobe K, Smith A, Kordower JH, Bakay RA. Deep brain stimulation for treatment of obesity in rats. J Neurosurg. 2007;107(4):809-813.
57. Folkow B, Rubinstein EH. Behavioural and autonomic patterns evoked by stimulation of the lateral hypothalamic area in the cat. Acta Physiol Scand. 1965; 65(4):292-299.
58. Delgado JM, Anand BK. Increase of food intake induced by electrical stimulation of the lateral hypothalamus. Am J Physiol. 1953;172(1):162-168.
59. Hoebel BG, Teitelbaum P. Hypothalamic control of feeding and self-stimulation. Science. 1962;135(3501):375-377.
60. Krasne FB. General disruption resulting from electrical stimulus of ventromedial hypothalamus. Science. 1962;138(3542):822-823.
61. Covalin A, Feshali A, Judy J. Deep Brain Stimulation for Obesity Control: analyzing stimulation parameters to modulate energy expenditure. Paper presented at: Proceedings of the 2nd International IEEE EMBS Conference on Neural Engineering; March 16-19, 2005; Arlington, Va.
62. Quaade F. Letter: stereotaxy for obesity. Lancet. 1974;1(7851):267.
63. Quaade F, Vaernet K, Larsson S. Stereotaxic stimulation and electrocoagulation of the lateral hypothalamus in obese humans. Acta Neurochir (Wien). 1974;30 (1-2):111-117.
64. Hamani C, McAndrews MP, Cohn M, et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol. 2008;63(1): 119-123.
65. Wilent WB, Oh MY, Buetefisch CM, et al. Induction of panic attack by stimulation of the ventromedial hypothalamus. J Neurosurg. 2010;112(6): 1295-1298.
66. Tessmar-Raible K, Raible F, Christodoulou F, et al. Conserved sensoryneurosecretory cell types in annelid and fish forebrain: insights into hypothalamus evolution. Cell. 2007;129(7):1389-1400.
67. Grill HJ, Skibicka KP, Hayes MR. Imaging obesity: fMRI, food reward, and feeding. Cell Metab. 2007;6(6):423-425.
68. Dagher A. The neurobiology of appetite: hunger as addiction. Int J Obes (Lond). 2009;33(suppl 2):S30-S33.
69. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004;306(5695): 503-507.
70. Kopell BH, Greenberg BD. Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci Biobehav Rev. 2008;32(3): 408-422.
71. Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 2000;20(6):2369-2382.
72. Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend. 2007;90(suppl 1):S85-S91.
73. Bickel WK, Johnson MW. Junk time: pathological behavior as the interaction of evolutionary and cultural forces. In: Heather N, Vuchinich R, eds. Choice, Behavioral Economics and Addictions. Amsterdam, Netherlands: Pergamon; 2003: 249-271.
74. Crean JP, de Wit H, Richards JB. Reward discounting as a measure of impulsive behavior in a psychiatric outpatient population. Exp Clin Psychopharmacol. 2000; 8(2):155-162.
75. Coffey SF, Gudleski GD, Saladin ME, Brady KT. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol. 2003;11(1):18-25.
76. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128(1): 78-87.
77. Madden GJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol. 1997;5(3):256-262.
78. Baker F, Johnson MW, Bickel WK. Delay discounting in current and neverbefore cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol. 2003;112(3):382-392.
79. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl). 1999; 146(4):447-454.
80. Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl). 1999;146(4):455-464.
81. Petry NM. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl). 2001;154 (3):243-250.
82. Richards JB, Zhang L, Mitchell SH, de Wit H. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav. 1999;71(2): 121-143.
83. Alessi SM, Petry NM. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes. 2003;64(3): 345-354.
84. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001;110(3): 482-487.
85. Petry NM, Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend. 1999;56(1):25-32.
86. Bonato DP, Boland FJ. Delay of gratification in obese children. Addict Behav. 1983;8(1):71-74.
87. Geller SE, Keane TM, Scheirer CJ. Delay of gratification, locus of control, and eating patterns in obese and nonobese children. Addict Behav. 1981;6(1):9-14.
88. Johnson WG, Parry W, Drabman RS. The performance of obese and normal size children on a delay of gratification task. Addict Behav. 1978;3(3-4):205-208.
89. Weller RE, Cook EW III, Avsar KB, Cox JE. Obese women show greater delay discounting than healthy-weight women. Appetite. 2008;51(3):563-569.
90. Davis C, Patte K, Curtis C, Reid C. Immediate pleasures and future consequences: a neuropsychological study of binge eating and obesity. Appetite. 2010;54(1):208-213.
91. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9: 357-381.
92. Koechlin E, Hyafil A. Anterior prefrontal function and the limits of human decision-making. Science. 2007;318(5850):594-598.
93. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008;118(7):2583-2591.
94. Ogawa H. Gustatory cortex of primates: anatomy and physiology. Neurosci Res. 1994;20(1):1-13.
95. Scott TR, Yaxley S, Sienkiewicz ZJ, Rolls ET. Gustatory responses in the frontal opercular cortex of the alert cynomolgus monkey. J Neurophysiol. 1986;56(3): 876-890.
96. Yaxley S, Rolls ET, Sienkiewicz ZJ. Gustatory responses of single neurons in the insula of the macaque monkey. J Neurophysiol. 1990;63(4):689-700.
97. Faurion A, Cerf B, Van De Moortele PF, Lobel E, Mac Leod P, Le Bihan D. Human taste cortical areas studied with functional magnetic resonance imaging: evidence of functional lateralization related to handedness. Neurosci Lett. 1999; 277(3):189-192.
98. Schoenfeld MA, Neuer G, Tempelmann C, et al. Functional magnetic resonance tomography correlates of taste perception in the human primary taste cortex. Neuroscience. 2004;127(2):347-353.
99. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004;7(2):189-195.
100. Craig AD. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10(1):59-70.
101. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3(8):655-666.
102. Craig AD. Human feelings: why are some more aware than others? Trends Cogn Sci. 2004;8(6):239-241.
103. Damasio AR, Grabowski TJ, Bechara A, et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 2000;3(10): 1049-1056.
104. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60(4): 383-387.
105. ChikamaM,McFarland NR, Amaral DG, Haber SN. Insular cortical projections to functional regions of the striatum correlate with cortical cytoarchitectonic organization in the primate. J Neurosci. 1997;17(24):9686-9705.
106. Naqvi NH, Bechara A. The hidden island of addiction: the insula. Trends Neurosci. 2009;32(1):56-67.
107. Haber SN, Kunishio K, Mizobuchi M, Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci. 1995;15(7 pt 1): 4851-4867.
108. Heimer L. Basal forebrain in the context of schizophrenia. Brain Res Brain Res Rev. 2000;31(2-3):205-235.
109. Klüver H, Bucy PC. Preliminary analysis of functions of the temporal lobes in monkeys. Arch Neurol Psychiatry. 1939;42(6):979-1000.
110. King BM. Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2006;291(5):R1201-R1214.
111. Rollins BL, King BM. Amygdala-lesion obesity: what is the role of the various amygdaloid nuclei? Am J Physiol Regul Integr Comp Physiol. 2000;279(4): R1348-R1356.
112. Rollins BL, Stines SG, King BM. Role of the stria terminalis in food intake and body weight in rats. Physiol Behav. 2006;89(2):139-145.
113. Pankey EA, Shurley MR, King BM. A re-examination of septal lesion-induced weight gain in female rats. Physiol Behav. 2008;93(1-2):8-12.
114. Figlewicz DP, Evans SB, Murphy J, Hoen M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 2003;964(1):107-115.
115. Figlewicz DP, Benoit SC. Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol. 2009;296(1):R9-R19.
116. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project tomultiple neuronal systems. J Neurosci. 1998;18(23):9996- 10015.
117. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35(1):4-26.
118. Davis JF, Choi DL, Benoit SC. Insulin, leptin and reward. Trends Endocrinol Metab. 2010;21(2):68-74.
119. Olds J. Self-stimulation of the brain; its use to study local effects of hunger, sex, and drugs. Science. 1958;127(3294):315-324.
120. Carr KD. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol Behav. 2002;76(3):353-364.
121. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565-598.
122. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8(11):1445-1449.
123. Stoeckel LE, Kim J, Weller RE, Cox JE, Cook EW III, Horwitz B. Effective connectivity of a reward network in obese women. Brain Res Bull. 2009;79(6): 388-395.
124. Stoeckel LE, Weller RE, Cook EW III, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage. 2008;41(2):636-647.
125. Rothemund Y, Preuschhof C, Bohner G, et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage. 2007;37(2):410-421.
126. Martin LE, Holsen LM, Chambers RJ, et al. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity (Silver Spring). 2010; 18(2):254-260.
127. Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD. Neural correlates of food addiction. Arch Gen Psychiatry. 2011;68(8):808-816.
128. Stice E, Yokum S, Bohon C, Marti N, Smolen A. Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4. Neuroimage. 2010;50(4):1618-1625.
129. Killgore WD, Yurgelun-Todd DA. Body mass predicts orbitofrontal activity during visual presentations of high-calorie foods. Neuroreport. 2005;16(8): 859-863.
130. Batterink L, Yokum S, Stice E. Body mass correlates inversely with inhibitory control in response to food among adolescent girls: an fMRI study. Neuroimage. 2010;52(4):1696-1703.
131. Bjork JM, Smith AR, Hommer DW. Striatal sensitivity to reward deliveries and omissions in substance dependent patients. Neuroimage. 2008;42(4):1609-1621.
132. Kirsch P, Reuter M, Mier D, et al. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett. 2006;405 (3):196-201.
133. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3191-3200.
134. Pliszka SR, Glahn DC, Semrud-Clikeman M, et al. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. Am J Psychiatry. 2006;163(6):1052-1060.
135. Horn NR, Dolan M, Elliott R, Deakin JF, Woodruff PW. Response inhibition and impulsivity: an fMRI study. Neuropsychologia. 2003;41(14):1959-1966.
136. Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry. 2005;58(8):597-604.
137. Paulus MP. Decision-making dysfunctions in psychiatry: altered homeostatic processing? Science. 2007;318(5850):602-606.
138. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007;315(5811):531-534.
139. Arana FS, Parkinson JA, Hinton E, Holland AJ, Owen AM, Roberts AC. Dissociable contributions of the human amygdala and orbitofrontal cortex to incentive motivation and goal selection. J Neurosci. 2003;23(29):9632-9638.
140. Killgore WD, Young AD, Femia LA, Bogorodzki P, Rogowska J, Yurgelun-Todd DA. Cortical and limbic activation during viewing of highversus low-calorie foods. Neuroimage. 2003;19(4):1381-1394.
141. LaBar KS, Gitelman DR, Parrish TB, Kim YH, Nobre AC, Mesulam MM. Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci. 2001;115(2):493-500.
142. Morris JS, Dolan RJ. Involvement of human amygdala and orbitofrontal cortex in hunger-enhanced memory for food stimuli. J Neurosci. 2001;21(14):5304-5310.
143. O'Doherty J, Rolls ET, Francis S, Bowtell R, McGlone F. Representation of pleasant and aversive taste in the human brain. J Neurophysiol. 2001;85(3): 1315-1321.
144. Zald DH, Lee JT, Fluegel KW, Pardo JV. Aversive gustatory stimulation activates limbic circuits in humans. Brain. 1998;121(pt 6):1143-1154.
145. Zald DH, Pardo JV. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proc Natl Acad Sci U S A. 1997; 94(8):4119-4124.
146. Petrovich GD, Ross CA, Mody P, Holland PC, Gallagher M. Central, but not basolateral, amygdala is critical for control of feeding by aversive learned cues. J Neurosci. 2009;29(48):15205-15212.
147. Gautier JF, Del Parigi A, Chen K, et al. Effect of satiation on brain activity in obese and lean women. Obes Res. 2001;9(11):676-684.
148. Gottfried JA, O'Doherty J, Dolan RJ. Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science. 2003;301(5636):1104-1107.
149. DiLeone RJ. The influence of leptin on the dopamine system and implications for ingestive behavior. Int J Obes (Lond). 2009;33(suppl 2):S25-S29.
150. Kim SE, Jin DK, Cho SS, et al. Regional cerebral glucose metabolic abnormality in Prader-Willi syndrome: a 18F-FDG PET study under sedation. J Nucl Med. 2006;47(7):1088-1092.
151. Halpern CH, Wolf JA, Bale TL, et al. Deep brain stimulation in the treatment of obesity. J Neurosurg. 2008;109(4):625-634.
152. Rezai AR, Machado AG, Deogaonkar M, Azmi H, Kubu C, Boulis NM. Surgery for movement disorders. Neurosurgery. 2008;62(suppl 2):809-838; discussion 838-839.
153. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362 (22):2077-2091.
154. Gabrils L, Cosyns P, Nuttin B, Demeulemeester H, Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand. 2003;107(4):275-282.
155. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessivecompulsive disorder. Lancet. 1999;354(9189):1526.
156. Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive-and anxiety-disorders. J Chem Neuroanat. 2003;26(4):293-299.
157. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384-2393.
158. Jiménez F, Velasco F, Salín-Pascual R, et al. Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir Suppl. 2007;97(pt 2):393-398.
159. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20): 2121-2134.
160. Quirk GJ, Likhtik E, Pelletier JG, Paré D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci. 2003;23(25):8800-8807.
161. Cohen MX, Axmacher N, Lenartz D, Elger CE, Sturm V, Schlaepfer TE. Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback. J Neurosci. 2009;29(23):7591-7598.
162. MantioneM, van de Brink W, Schuurman PR, Denys D. Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report. Neurosurgery. 2010;66(1): E218; discussion E218.
163. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010;13(5): 635-641.
164. Johansen-Berg H, Gutman DA, Behrens TE, et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex. 2008;18(6):1374-1383.
165. Gutman DA, Holtzheimer PE, Behrens TE, Johansen-Berg H, Mayberg HS. A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry. 2009;65(4):276-282.
166. Lozano AM,Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461-467.